Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Electricity and Smart Grid (1)
- (-) Isotopes (1)
- Advanced Manufacturing (7)
- Biology and Environment (54)
- Building Technologies (2)
- Clean Energy (101)
- Climate and Environmental Systems (1)
- Computational Engineering (3)
- Computer Science (15)
- Energy Sciences (1)
- Functional Materials for Energy (1)
- Fusion and Fission (8)
- Fusion Energy (3)
- Materials (63)
- Materials for Computing (11)
- Mathematics (1)
- National Security (21)
- Neutron Science (25)
- Nuclear Science and Technology (5)
- Quantum information Science (7)
- Supercomputing (118)
News Topics
- (-) Computer Science (2)
- (-) Frontier (1)
- (-) Sustainable Energy (1)
- Artificial Intelligence (2)
- Biology (2)
- Biomedical (7)
- Buildings (1)
- Climate Change (1)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (2)
- Grid (3)
- High-Performance Computing (3)
- Irradiation (1)
- Isotopes (24)
- Machine Learning (1)
- Materials (5)
- Materials Science (3)
- Microelectronics (1)
- National Security (1)
- Neutron Science (1)
- Nuclear Energy (3)
- Security (1)
- Simulation (1)
- Space Exploration (4)
- Summit (1)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.